SCIENTIFIC PROGRAMThe Liver Week 2020 Virtual Conference

The Liver Week 2020 Virtual Confernence [DAY 1: Thursday, August 13, 2020]

PROGRAM BOOK DOWNLOAD

08:40-09:00
The Liver Week 2020 Opening Ceremony
09:00-09:05
ISALPDC Opening Ceremony
09:00-10:10

Real Time Discussion

KASL Symposium 1. Up-to-Date Treatment for Liver Diseases
Dong Joon Kim (Hallym Univ.), Joo Hyun Sohn (Hanyang Univ.)
09:00-09:20
Pharmacological Treatment of Alcoholic HepatitisGyongyi Szabo (Harvard Univ., USA)
09:20-09:40
Pharmacological Treatment of Nonalcoholic SteatohepatitisManal Abdelmalek (Duke Univ., USA)
09:40-10:00
New Horizon of Immuno-Oncologic TherapyAmit Singal (Univ. of Texas Southwestern, USA)
10:00-10:10
Discussion
09:00-10:10
PG1. Current Issues in Chronic Hepatitis B
09:00-09:10
Case Presentation and Key QuestionsHyun Woong Lee (Yonsei Univ.)
09:10-09:30
Immune Tolerant Chronic Hepatitis B: To Treat or Not?Jonggi Choi (Univ. of Ulsan)
09:30-09:50
Risks and Benefits of Antiviral Therapy During PregnancyYoung-Sun Lee (Korea Univ.)
09:50-10:10
Prophylactic Antiviral Therapy for Hepatitis B During Immunosuppressive TherapyIn Hee Kim (Chonbuk National Univ.)
09:05-11:00

Real Time Discussion

ISALPDC 1. Obesity-Alcohol Synergism
Won-IL Jeong (KAIST), Kenichi Ikejima (Juntendo Univ., Japan)
09:05-09:25
Obesity and Alcohol Are Deadly Combination to Induce SteatohepatitisBin Gao (National Institutes of Health, USA)
09:25-09:45
Alcohol-NAFLD InteractionsKenichi Ikejima (Juntendo Univ., Japan)
09:45-10:05
Autophagy Regulation in Alcoholic and Non-Alcoholic Liver SteatosisSang Geon Kim (Seoul National Univ.)
10:05-10:25
Alcohol-NAFLD Interactions in a Large Korean Cohort StudyYong Kyun Cho (Sungkyunkwan Univ.)
10:25-10:35
Interaction between CD40L and CD40 Mediates Hepatic Exosomal Delivery to Kupffer Cells in Alcoholic Liver DiseaseKyurae Kim (KAIST)
10:35-10:45
The Effect of Intestinal Flora Modification on Alcoholic Liver Injury in Obese KK-Ay MiceKazuyoshi Kon (Juntendo Univ., Japan)
10:45-11:00
Round Table Discussions
10:20-11:20

Real Time Discussion

Plenary Presentation 1
Kwan Sik Lee (Yonsei Univ.), Kwan Soo Byun (Korea Univ.), Ho Seong Han (Seoul National Univ.)
11:00-13:00

Real Time Discussion

ISALPDC 2. Novel Cellular and Organ Crosstalk in Alcoholic Liver Disease
Bin Gao (National Institutes of Health, USA ), Yasuko Iwakiri (Yale Univ., USA)
11:00-11:20
Neuroendocrine-Fat-Liver AxisLaura E. Nagy (Cleveland Clinic, USA)
11:20-11:40
Lymphatic System and Organ CrosstalkYasuko Iwakiri (Yale Univ., USA)
11:40-12:00
Liver-Lung CrosstalkGavin E. Arteel (Univ. of Pittsburgh, USA)
12:00-12:20
Glutamate/mGluR5-mediated Endocannabinoid in Alcoholic Fatty LiverWon-IL Jeong (KAIST)
12:20-12:30
CYP2E1 Regulation of Ethanol-Induced Intestinal miRNAs in Liver InjuryJe-Hyun Yoon (Medical Univ. of South Carolina, USA)
12:30-12:40
Chronic Alcohol Consumption Alters the Phenotype of F4/80+CD11b+ Bone Marrow Cells by Neuro-Metabolic Signaling PathwayYoung-Ri Shim (KAIST)
12:40-13:00
Round Table Discussions
11:30-12:00
State-of-the-Art Lecture
Seung Woon Paik (Sungkyunkwan Univ.)
Past, Present, and Future of Precision Hepatology: Where Do We Need to Go?W. Ray Kim (Stanford Univ., USA)
11:30-12:40
PG2. Current Issues in Chronic Hepatitis C
11:30-11:40
Case Presentation and Key QuestionsHyun Woong Lee (Yonsei Univ.)
11:40-12:00
Retreatment Options for Chronic Hepatitis C after Oral Direct-Acting Antiviral Agent FailureJung Hyun Kwon (The Catholic Univ. of Korea)
12:00-12:20
Risks and Benefits of Oral Direct-Acting Antiviral Agent Therapy in Patients with Hepatitis C Virus-Related Hepatocellular CarcinomaNae-Yun Heo (Inje Univ.)
12:20-12:40
Hepatocellular Carcinoma Surveillance in Chronic Hepatitis C Patients Who Achieved Sustained Virological Response Yun Bin Lee (Seoul National Univ.)
12:10-12:55
Satellite Symposium 1 Bayer
12:40-13:25
Satellite Symposium 2 Gilead
13:00-13:45
Satellite Symposium 3 AbbVie
13:00-14:30

Real Time Discussion

KLCA Symposium 1. The Changing Landscape and New Evidences in Treatment Strategies for Hepatocellular Carcinoma
Joong-Won Park (National Cancer Center Korea), Jung-Hwan Yoon (Seoul National Univ.)
13:00-13:20
Current Evidences and Future Perspectives for the Treatment of Advanced Hepatocellular CarcinomaJeong Won Jang (The Catholic Univ. of Korea)
13:20-13:40
When Should We Consider Systemic Therapy in BCLC Stage B Hepatocellular Carcinoma?Hyung Joon Yim (Korea Univ.)
13:40-14:00
Therapeutic Efficacy of Transarterial-Based Treatment vs. Targeted Therapy in Advanced Hepatocellular CarcinomaSadahisa Ogasawara (Chiba Univ., Japan)
14:00-14:20
Optimizing Therapeutic Efficacy with Systemic Treatment and Radiotherapy in Hepatocellular CarcinomaJinsil Seong (Yonsei Univ.)
14:20-14:30
Discussion
13:30-14:40
PG3. Consensus on the Management of Nonalcoholic Fatty Liver Disease
13:30-13:40
Case Presentation and Key Questions Young-Joo Jin (Inha Univ.)
13:40-14:00
Assessment of Co-Morbidities in Patients with Nonalcoholic Fatty Liver DiseaseJung Il Lee (Yonsei Univ.)
14:00-14:20
Pathogenesis and Management of Non-Obese Nonalcoholic Fatty Liver DiseaseHwi Young Kim (Ewha Womans Univ.)
14:20-14:40
Currently Available Treatment Strategy in Patients with Nonalcoholic Steatohepatitis and Metabolic SyndromeWon Sohn (Sungkyunkwan Univ.)
14:00-15:10

Real Time Discussion

General Oral Presentation 1
Myung Seok Lee (Hallym Univ.), Byung Ik Kim (Sungkyunkwan Univ.)
14:40-15:50

Real Time Discussion

LCGSJ-KLCA Joint Symposium. Similarities and Differences in HCC Management
Shoji Kubo (Osaka City Univ., Japan), Jin Wook Chung (Seoul National Univ.)
14:40-14:55
Current Approaches to the Treatment of Early HCC in JapanShuichiro Shiina (Juntendo Univ., Japan)
14:55-15:10
Current Approaches to the Treatment of Early HCC in KoreaMyeong Jun Song (The Catholic Univ. of Korea)
15:10-15:25
Selection of Particle Beam vs. Photon Beam Radiation Therapy for HCC: Japanese ExperienceHideyuki Sakurai (Univ. of Tsukuba, Japan)
15:25-15:40
Selection of Particle Beam vs. Photon Beam Radiation Therapy for HCC: Korean ExperienceHee Chul Park (Sungkyunkwan Univ.)
15:40-15:50
Discussion
14:50-16:00
PG4. Assessment and Management of Liver Cirrhosis Complications
14:50-15:00
Case Presentation and Key Questions Young-Joo Jin (Inha Univ.)
15:00-15:20
How to Assess Minimal Hepatic Encephalopathy in Patients with Liver Cirrhosis?Eileen L. Yoon (Inje Univ.)
15:20-15:40
When and How to Use Anticoagulants for Benign Portal Vein Thrombosis in Patients with Liver CirrhosisYoung Kul Jung (Korea Univ.)
15:40-16:00
Update of Beta Blocker and Albumin Use for Patients with Decompensated Liver CirrhosisKi Tae Yoon (Pusan National Univ.)
15:10-18:10
Abdominal Ultrasonography Training Course for Certified Trainer
15:10-15:30
Introduction to Ultrasonography Training Program for Trainer and Trainee of KASLMoon-Young Kim (Yonsei Univ. Wonju)
15:30-15:50
Useful Tips for Setting-up of Ultrasound RoomsSoo Young Park (Kyungpook National Univ.)
15:50-16:10
Experience of Ultrasonography Education Programs for Residents and Fellows in KoreaJun Yong Park (Yonsei Univ.)
16:10-16:30
Tips for Ultrasonography Examination in Patients with Poor Sonographic WindowJaeyoun Cheong (Ajou Univ.)
16:30-16:50
Contrast-enhanced Ultrasonography in the Diagnosis of Focal Liver LesionsSae Hwan Lee (Soonchunhyang Univ.)
16:50-17:10
Ultrasonography-guided Procedures: Percutaneous Drainage Insertion and Liver Biopsy Seung Whan Cha (Yonsei Univ. Wonju)
17:10-17:30
Clinical Application of Liver Stiffness and Viscosity Measurement Using Shear Wave ElastographySang Gyune Kim (Soonchunhyang Univ.)
17:30-17:50
Technological advancement in Ultrasonography: Real-Time Fusion Imaging of Liver Ultrasonography with CT or MRI Ji Young Kwon (Canon Medical Systems)
17:50-18:10
Comparison Between Transabdominal Ultrasonography and Endoscopic Ultrasonography for the Diagnosis of Pancreaticobiliary DiseaseYoung Koog Cheon (Konkuk Univ.)
16:00-17:30

Real Time Discussion

KASL Symposium 2. New Insights to Unanswered Issues in Treatment for Chronic Hepatitis B
Seung Kew Yoon (The Catholic Univ. of Korea), Kyun-Hwan Kim (Sungkyunkwan Univ.)
16:00-16:20
Exploring Unrecognized Risks in Immune Tolerant Phase of Chronic Hepatitis BYoung-Suk Lim (Univ. of Ulsan)
16:20-16:40
Clonal Hepatocyte Expansion and Hepatitis B Virus IntegrationPatrick Kennedy (Queen Mary Univ. of London, UK)
16:40-17:00
Effect of Current and Novel Antivirals on the Prevention of Hepatocellular Carcinoma: Beyond Viral SuppressionGeorge V. Papatheodoridis (National and Kapodistrian Univ. of Athens, Greece)
17:00-17:20
Functional Cure of Chronic Hepatitis B and BeyondMan-Fung Yuen (The Univ. of Hong Kong, Hong Kong)
17:20-17:30
Discussion
16:10-17:30
PG for Basic Research
16:10-16:30
Assessment of Mitochondrial Function in Liver ResearchHyon-Seung Yi (Chungnam National Univ.)
16:30-16:50
Selection and Utilization of Murine Models in Liver ResearchSeung-Jin Kim (Kangwon National Univ.)
16:50-17:10
Basic Understanding of Genomics and Proteomics StudyJu-Seog Lee (MD Anderson Cancer Center, USA)
17:10-17:30
A Noble and Powerful Tool: Single Cell RNA SequencingYoung Seok Ju (KAIST)